Life Sciences Update – Investments in Life Sciences
Welcome to the second Life Sciences Update of 2026
The life sciences industry remains a magnet for substantial investment, yet the landscape is becoming increasingly challenging due to heightened regulatory scrutiny and rapid scientific advances.
While the programme is still being developed, we can already share that it will explore the strategic, commercial, and financial considerations that drive value creation in the life sciences sector. Through panel discussions and expert presentations, participants will gain insights into building a compelling equity story, preparing for partnering and M&A opportunities, navigating financing and valuation challenges, and understanding the latest regulatory developments affecting life sciences investments.
The programme will feature speakers from leading investors as well as representatives from biotech companies at both the fundraising and exit stages, including Hemab, Adcendo, Forbion and Sofinnova.
Whether you are an investor, a company preparing for funding or an exit, or simply interested in the dynamics shaping the sector, this event offers valuable insights and practical perspectives from industry insiders.
We look forward to welcoming you to a dynamic programme featuring contributions from our in-house specialists and distinguished industry participants, followed by an opportunity to connect with peers over lunch.
Programme
The programme is currently being developed, and we will share the full agenda shortly.
Time and venue
Date: Monday, 31 August 2026
Time: 09:00–13:00 (registration and a light breakfast from 08:30)
Venue: Gorrissen Federspiel, Axel Towers, Axeltorv 2, 1609 Copenhagen V
Registration
The event is fully booked. Please contact events@gorrissenfederspiel.com to join the waiting list.